TGFB1 and non-small cell lung carcinoma: In summary, our results indicate that monitoring plasma concentrations of TNF-α, IL-1β, IL-6 and TGF-β1 does not allow a predictive risk assessment for RP in patients irradiated for advanced NSCLC.